WHO’s antibacterial pipeline reports

  22 September 2022

The antibacterial pipeline report details preclinical and clinical studies of traditional and novel antibacterial agents worldwide. It offers an assessment of criteria for innovation, such as the known absence of cross-resistance to drugs or new targets or modes of action. The vaccine pipeline report lists 61 vaccine candidates in various stages of clinical development and a further 94 candidates that are in the preclinical stage. It also discusses WHO’s position on the science of vaccines and their role in reducing the spread of AMR and saving lives, and the case for new investments.

Further reading: The Lancet
Author(s): Vijay Shankar Balakrishnan
Effective Surveillance  


Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition


JSS University


Technology Database

Display your AMR Technology, Product and Service

Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.

Read more and make your own Technology Page >>
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!